[ACCI-CAVIE] The Nigerian pharmaceutical industry is poised for significant growth, with ambitious plans to increase local drug production to 70%.

This announcement was made by Prof. Mojisola Adeyeye, Director-General of the National Agency for Food and Drug Administration and Control (NAFDAC), at the 7th Nigeria Pharma Manufacturers’ EXPO.   Adeyeye revealed that local drug production has already surpassed 30% and is approaching 40%. This progress is a testament to the industry’s efforts to reduce Nigeria’s dependence on imported medicines and ensure drug security, quality, and affordability for its citizens.

Global Recognition

Swiss Pharma Nigeria Ltd., a domestic manufacturer, has achieved a significant milestone by having two of its antimalarial drugs added to the World Health Organization’s (WHO) list of pre-qualified medicines. This recognition highlights the quality and efficacy of Nigerian-made pharmaceuticals and reinforces the country’s position in the global pharmaceutical market.

Tackling Counterfeit Medicines

NAFDAC has identified a pressing issue within the Nigerian pharmaceutical sector: over 50% of certificates for imported pharmaceutical products are counterfeit. This alarming statistic underscores the need for stringent measures to combat the proliferation of substandard and falsified medicines.

Government Initiatives

To address the challenges faced by the pharmaceutical sector, the Nigerian government has implemented several initiatives. The suspension of import duties on staple food items, drugs, and other essential goods aims to alleviate economic pressures on citizens and mitigate the impact of inflation. Additionally, the Centre for the Promotion of Private Enterprise (CPPE) has advocated for the elimination of duties on pharmaceutical imports to reduce costs for consumers.

Nigeria’s pharmaceutical sector is on a transformative path, with a strong focus on increasing local production and ensuring the quality and affordability of medicines. By addressing challenges such as counterfeit products and implementing supportive policies, Nigeria can strengthen its pharmaceutical industry and improve the health and well-being of its citizens.

The editorial team